untitled design

The Pfizer-BioNTech vaccine is 100 percent effective in the 12 to 15 year age range

Pfizer / Biontech announced that its Comirnaty mRNA vaccine is 100% effective in the age group between 12 and 15 years. The news comes directly from the United States and follows the new administration trials that in recent months have continued to evaluate the anti-Covid coverage of the vaccine on the population under the age of 16, the maximum age for administration up to now.

In a note released in these hours, the CEO of Pfizer Albert Bourla said the company plans to submit new data on the vaccine, developed in collaboration with German pharmaceutical manufacturer BioNTech, to the Food and Drug Administration and other drug approval bodies “as soon as possible,” with the hope that children in the new age range included can get vaccinated before the next school year.

“We share the urgency of extending the authorization of the use of our vaccine in younger populations and are encouraged by the data from clinical trials on adolescents aged 12 to 15,” Bourla said in the statement, as reported by CNBC. .

The studies were conducted in the United States out of 2,260 participants, with 18 confirmed Covid-19 infections being found in the placebo group and no confirmed infections in the vaccine-receiving group. This led to a 100% efficacy of Comirnaty, as well as a good injection tolerance, with side effects generally consistent with those seen in adults..

The pharmaceutical company further stated that the vaccine produces a “robust” antibody response in children, higher than that of a previous study of 16-25 year olds. It will now be necessary to wait for the technical times for examining the data, by the bodies responsible for the control of drugs, in order to have the go-ahead for the administration within the next few months.

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular